Affordable Access

Repeated botulinum toxin injection for idiopathic overactive bladder: will chemodenervation become a long-term solution?

Authors
Type
Published Article
Journal
Current urology reports
Publication Date
Volume
8
Issue
5
Pages
419–424
Identifiers
PMID: 17880843
Source
Medline

Abstract

Botulinum toxin A (BTX-A) has emerged as a novel treatment option for idiopathic overactive bladder (OAB) refractory to antimuscarinic agents. The clinical needs of refractory OAB patients have been recently met by sacral neuromodulation and augmentation enterocystoplasty. Important features of BTX-A should include safety, efficacy, and ease of delivery during long-term repeated usage. This article reviews the role of repeated BTX-A injections in the treatment of idiopathic OAB.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F